Total Payments
$9,441
2024 Payments
$491.46
Companies
56
Transactions
728
Medicare Patients
2,152
Medicare Billing
$270,718
Payment Breakdown by Category
Food & Beverage$9,274 (98.2%)
Other$161.25 (1.7%)
Education$5.79 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,274 | 718 | 98.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $161.25 | 9 | 1.7% |
| Education | $5.79 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,073 | 121 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $736.54 | 55 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $625.29 | 60 | $0 (2021) |
| Biogen, Inc. | $501.28 | 35 | $0 (2024) |
| EMD Serono, Inc. | $450.98 | 51 | $0 (2023) |
| Amgen Inc. | $437.25 | 27 | $0 (2022) |
| Avanir Pharmaceuticals, Inc. | $425.19 | 26 | $0 (2020) |
| Alexion Pharmaceuticals, Inc. | $396.38 | 27 | $0 (2021) |
| Supernus Pharmaceuticals, Inc. | $377.09 | 32 | $0 (2019) |
| Mallinckrodt Enterprises LLC | $338.62 | 21 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $491.46 | 47 | ABBVIE INC. ($263.35) |
| 2023 | $474.88 | 30 | ABBVIE INC. ($244.20) |
| 2022 | $661.64 | 44 | Amgen Inc. ($215.17) |
| 2021 | $581.58 | 62 | AbbVie Inc. ($267.24) |
| 2020 | $1,633 | 111 | Teva Pharmaceuticals USA, Inc. ($140.79) |
| 2019 | $2,551 | 220 | Teva Pharmaceuticals USA, Inc. ($273.09) |
| 2018 | $1,897 | 136 | Supernus Pharmaceuticals, Inc. ($190.79) |
| 2017 | $1,150 | 78 | Mallinckrodt LLC ($152.83) |
All Payment Transactions
728 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Neuromodulation | ||||||
| 12/18/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: Neurology | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Neurology | ||||||
| 10/28/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $0.89 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $0.67 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Neurology | ||||||
| 10/07/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $1.91 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $0.67 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $1.71 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $0.67 | General |
| Category: NEUROSCIENCE | ||||||
| 09/03/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Neurology | ||||||
| 08/20/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Neurology | ||||||
| 08/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: NEUROSCIENCE | ||||||
| 08/19/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $1.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/29/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $0.61 | General |
| Category: NEUROSCIENCE | ||||||
| 07/23/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: NEUROSCIENCE | ||||||
| 07/15/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $1.32 | General |
| Category: NEUROSCIENCE | ||||||
| 07/03/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: NEUROSCIENCE | ||||||
| 07/02/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $1.97 | General |
| Category: NEUROSCIENCE | ||||||
| 07/01/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $1.15 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $2.08 | General |
| Category: NEUROSCIENCE | ||||||
| 06/24/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $0.56 | General |
| Category: NEUROSCIENCE | ||||||
| 06/19/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: Neurology | ||||||
| 06/14/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 544 | 2,493 | $354,041 | $72,474 |
| 2022 | 13 | 546 | 3,052 | $329,558 | $70,214 |
| 2021 | 12 | 578 | 792 | $294,506 | $76,917 |
| 2020 | 10 | 484 | 2,084 | $153,833 | $51,113 |
Total Patients
2,152
Total Services
8,421
Medicare Billing
$270,718
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 230 | 452 | $165,884 | $35,850 | 21.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 81 | 81 | $38,308 | $9,277 | 24.2% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 23 | 23 | $28,727 | $7,123 | 24.8% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 41 | 74 | $21,238 | $5,164 | 24.3% |
| 70551 | Mri scan of brain without contrast | Office | 2023 | 41 | 41 | $35,178 | $3,802 | 10.8% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 27 | 27 | $17,307 | $3,795 | 21.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 27 | $13,851 | $2,730 | 19.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 52 | 56 | $14,448 | $2,717 | 18.8% |
| 70553 | Mri scan of brain before and after contrast | Office | 2023 | 12 | 12 | $17,400 | $1,831 | 10.5% |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | Office | 2023 | 13 | 1,700 | $1,700 | $185.04 | 10.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 185 | 340 | $124,780 | $27,735 | 22.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 100 | 129 | $33,282 | $6,551 | 19.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 62 | 62 | $29,388 | $6,464 | 22.0% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2022 | 19 | 19 | $23,731 | $5,827 | 24.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 38 | 71 | $20,377 | $5,313 | 26.1% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 31 | 31 | $19,871 | $5,022 | 25.3% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 15 | 15 | $15,645 | $4,170 | 26.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 18 | 18 | $10,224 | $2,678 | 26.2% |
| 70551 | Mri scan of brain without contrast | Office | 2022 | 27 | 27 | $23,166 | $2,596 | 11.2% |
| 70553 | Mri scan of brain before and after contrast | Office | 2022 | 12 | 12 | $17,400 | $1,892 | 10.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 14 | $7,182 | $1,482 | 20.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 14 | $2,212 | $247.13 | 11.2% |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | Office | 2022 | 15 | 2,300 | $2,300 | $238.25 | 10.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 155 | 261 | $86,129 | $23,302 | 27.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 125 | 178 | $36,092 | $9,450 | 26.2% |
About Cara Pendley
Cara Pendley is a Neurology healthcare provider based in Cordova, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/19/2007. The National Provider Identifier (NPI) number assigned to this provider is 1376760439.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Cara Pendley has received a total of $9,441 in payments from pharmaceutical and medical device companies, with $491.46 received in 2024. These payments were reported across 728 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($9,274).
As a Medicare-enrolled provider, Pendley has provided services to 2,152 Medicare beneficiaries, totaling 8,421 services with total Medicare billing of $270,718. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Cordova, TN
- Active Since 04/19/2007
- Last Updated 03/06/2017
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1376760439
Products in Payments
- UBRELVY (Drug) $507.85
- TECFIDERA (Drug) $431.87
- BOTOX (Biological) $415.30
- Aimovig (Biological) $407.40
- ACTHAR (Biological) $401.21
- AJOVY (Drug) $379.41
- NUEDEXTA (Drug) $370.84
- OCREVUS (Biological) $328.05
- TROKENDI XR (Drug) $319.98
- APTIOM (Drug) $279.88
- GILENYA (Drug) $227.58
- SOLIRIS (Drug) $215.28
- INGREZZA (Drug) $192.60
- RYTARY (Drug) $184.50
- KESIMPTA (Drug) $182.62
- AJOVY (Biological) $175.09
- AIMOVIG (Biological) $174.51
- INBRIJA (Drug) $161.25
- TEGSEDI (Drug) $146.71
- LYRICA (Drug) $140.33
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Cordova
Lee Stein, Md, MD
Neurology — Payments: $512,903
Neurology $512,903
Dr. Oleksandra Dryn, M.d, M.D
Neurology — Payments: $109,164
Neurology $109,164
Dr. Thomas Arnold, M.d, M.D
Neurology — Payments: $47,871
Neurology $47,871
Kendrick Henderson, Md, MD
Neurology — Payments: $31,757
Neurology $31,757
Dr. David Pritchard, M.d, M.D
Neurology — Payments: $27,827
Neurology $27,827
Bola Adamolekun, Md, MD
Neurology — Payments: $27,159
Neurology $27,159